Asymchem Laboratories (Tianjin) Company
.jpg)
Asymchem Laboratories (Tianjin) is focused on the R&D of the pharmaceutical raw materials synthesis technology and more.
Funding Status:
IPO
Industry:
Preclinical Development
Estimated Revenue:
$100M to $500M
Technology:
Medical
Headquarters:
Tianjin, Guangdong, China
Last Funding Date:
2011-08-01
Last Funding Type:
Seed
Employee Number:
5001-10000
Investors Number:
1.0
Founded Date:
1998-01-01